SEP 7, 2026 · JOURNAL ARTICLE
Cu-deficient Cu–Fe Prussian blue analogues enable phosphate/GSH-coupled redox remodeling for catalytic/sonodynamic cancer therapy
Journal of Nanobiotechnology
Early-stage preclinical study demonstrating a novel nanoparticle design in cell culture and a single murine tumor model, without clinical translation, efficacy comparators, or mechanistic validation beyond correlative evidence.
Reported
Tumor model4T1 breast tumor
Treatment outcomemarkedly suppressed tumor growth
Biosafetyfavorable under tested conditions